Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial
1 other identifier
observational
7,660
1 country
1
Brief Summary
This study is a randomized control prospective study. The aim of this study is to establish an all-round and convenient follow-up strategy of Chronic Hepatitis B for early detection and diagnosis of Hepatocellular Carcinoma (HCC), by investigating whether different surveillance time intervals and surveillance methods are beneficial for chronic hepatitis B and cirrhotic patients with different risk of HCC.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 27, 2016
CompletedFirst Posted
Study publicly available on registry
June 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2020
CompletedJune 29, 2016
June 1, 2016
4 years
June 27, 2016
June 27, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The incidence of Hepatocellular carcinoma
3 year
Study Arms (6)
1
Chronic Hepatitis B patient
2
Chronic Hepatitis B patient
3
cirrhotic patient
4
cirrhotic patient
5
ultrasound-difficult patient
6
ultrasound-difficult patient
Interventions
Eligibility Criteria
Chronic Hepatitis B patients
You may qualify if:
- HBV-Ag positive( \>6 months)
- age among 18 and 80 years
You may not qualify if:
- patients with hepatocellular carcinoma
- patients with alcoholic hepatitis or autoimmune hepatitis
- patients with severe uncontrolled disease resulting in estimated life expectance less than 1 year
- coinfection with human immunodeficiency virus(HIV)
- cannot undergo contrast-enhanced imaging
- refuse attending the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The department of Ultrasound, the third affiliated hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
zhongzhen zz Su, doctor
The department of Ultrasound, the third affiliated hospital of Sun Yat-sen University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 27, 2016
First Posted
June 29, 2016
Study Start
May 1, 2016
Primary Completion
May 1, 2020
Last Updated
June 29, 2016
Record last verified: 2016-06
Data Sharing
- IPD Sharing
- Will not share